CONSIDERATIONS TO KNOW ABOUT TEMAZEPAM

mavorixafor will boost the degree or outcome of triazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. Keep an eye on for adverse consequences of sensitive CYP3A4 substrates if coadministered with mavorixafor (a weak CYP3A4 inhibitor).Tolerance to estazolam may possibly build from continued therapy. Toleran